FDAnews
www.fdanews.com/articles/74509-diachrome-improves-cardiovascular-disease-risk-factors

DIACHROME IMPROVES CARDIOVASCULAR DISEASE RISK FACTORS

July 20, 2005

Nutrition 21 reported results from a new clinical study that add to the growing body of clinical data demonstrating that daily supplementation with Diachrome, a combination of chromium picolinate and biotin, can significantly reduce cardiovascular disease risk factors in people with Type 2 diabetes.

The study results include an analysis of subjects with Type 2 diabetes who were moderately obese and taking oral antidiabetic medications. When Diachrome was added to daily treatment regimens, the atherogenic index of plasma, a predictive marker for cardiovascular disease that examines triglyceride and HDL cholesterol levels (good cholesterol), was significantly lower compared with the placebo group.

Diachrome is a nutritional supplement specifically formulated for people with diabetes. It contains 600 mcg of chromium as Chromax chromium picolinate and 2 mg of biotin. These two compounds are both generally recognized as safe for use as ingredients in food and supplements.